Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from XBiotech ( (XBIT) ) is now available.
On March 27, 2025, W. Thorpe McKenzie retired from the Board of Directors of XBiotech Inc., a company in the biotechnology sector, after serving since 2009. His departure was amicable and not due to any disputes. The company plans to maintain a one-member Audit Committee temporarily and intends to fill the vacancies in compliance with NASDAQ rules.
More about XBiotech
XBiotech Inc. operates in the biotechnology industry, focusing on developing therapies for various diseases.
YTD Price Performance: -22.30%
Average Trading Volume: 51,270
Technical Sentiment Signal: Buy
Current Market Cap: $94.51M
See more data about XBIT stock on TipRanks’ Stock Analysis page.